ACRO Unveils Power Squad for 2024: Meet the New Faces
The Association of Clinical Research Organizations (ACRO) announced the election of Peyton Howell, Chief Operating & Growth Officer at...
Adaptive Clinical Trial Design Adaptive Trial Design AI in Clinical Trials alcohol use disorder Alzheimer's Disease Article Clinical Operations Clinical Research Clinical Trial Design Clinical Trial Operations Clinical Trial Ops Brief Clinical Trial Quality Clinical Trials CLINOPS WATCHDOG CNS Trials Conference Coverage Decentralized Clinical Trials Digital Health Technologies DOGE FDA Budget Cuts dual diagnosis eClinical Tech News eClinical Technology EMA Executive Interviews FDA Enforcement FDA Guidance FDA Real-World Evidence FDA Regulation FDA Regulatory Strategy FDA Warning Letter GCP Compliance GLP-1 Receptor Agonists Ketamine Therapy Oncology Trials Opinion Parkinson's Disease Platform Trials Psilocybin MDMA Psychedelic Clinical Trials PSYCH PULSE Real-World Evidence site activation Site Operations study startup Treatment-Resistant Depression
The Association of Clinical Research Organizations (ACRO) announced the election of Peyton Howell, Chief Operating & Growth Officer at...
Kite, a Gilead Company (Nasdaq: GILD), has presented encouraging data from various studies on the CAR T-cell therapies Tecartus®...
A new clinical trial, known as the AERIFY-2 study, is underway in Mooresville, N.C., focusing on chronic obstructive pulmonary...
Pfizer Inc. has reached a significant milestone in its pending acquisition of Seagen Inc., with all required regulatory approvals...
This interview features the innovative world of decentralized clinical trials (DCTs) with insights from Darcy Forman of Science 37....
Merck, and Moderna, Inc., have launched INTerpath-002, a pivotal Phase 3 randomized clinical trial for a cancer vaccine. The...
Innate Pharma SA, in collaboration with Sanofi, shared updated efficacy and safety results from a Phase 1/2 dose-escalation study...
Merck and Eisai have reported that the Phase 3 LEAP-001 trial for the first-line treatment of patients with advanced...
Pfizer Inc. has shared promising results from its pivotal Phase 3 BASIS clinical trial of marstacimab, a potential new...
Today we delve into the dynamic world of clinical trials. This discussion aims to uncover the intricacies and challenges...